Anlotinib In Combination With PD-1/L1 Inhibitor As Sequential Therapy of Thoracic Radiotherapy After Induction Chemotherapy For Extensive-Stage Small Cell Lung Cancer:A Single Arm Study
Clinical trial NCT04313660 · UNKNOWN
Trial details
- NCT number
- NCT04313660
- Sponsor
- Xiaorong Dong
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-01
- Primary completion
- 2021-02-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.